Axogen Inc Stock Performance
| AXGN Stock | USD 6.50 0.05 0.76% |
The firm shows a Beta (market volatility) of 2.58, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Axogen will likely underperform. Axogen Inc has an expected return of -0.46%. Please make sure to confirm Axogen Inc information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if Axogen Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Axogen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in May 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (5.62) | Five Day Return (9.90) | Year To Date Return (5.21) | Ten Year Return 133.93 | All Time Return 63.94 |
Last Split Factor 105:100 | Dividend Date 2010-02-12 | Ex Dividend Date 2010-01-27 | Last Split Date 1994-07-11 |
1 | Acquisition by Marc Began of 68600 shares of Axogen subject to Rule 16b-3 | 02/22/2024 |
2 | Acquisition by Jens Kemp of 68600 shares of Axogen subject to Rule 16b-3 | 02/23/2024 |
3 | Acquisition by Erick DeVinney of 50000 shares of Axogen subject to Rule 16b-3 | 03/01/2024 |
4 | AxoGen Non-GAAP EPS of -0.06 beats by 0.02, revenue of 42.9M beats by 1.9M | 03/05/2024 |
5 | Disposition of 25000 shares by Gregory Freitag of Axogen at 9.0 subject to Rule 16b-3 | 03/07/2024 |
6 | Disposition of 90000 shares by Marc Began of Axogen at 8.16 subject to Rule 16b-3 | 03/11/2024 |
7 | Disposition of 3000 shares by Michael Donovan of Axogen subject to Rule 16b-3 | 03/15/2024 |
8 | Disposition of 716 shares by Michael Donovan of Axogen at 7.68 subject to Rule 16b-3 | 03/21/2024 |
9 | Axogens chief innovation officer sells over 35k in stock | 03/26/2024 |
10 | Positive Sentiment Still Eludes AxoGen, Inc. Following 26 percent Share Price Slump | 03/28/2024 |
11 | Disposition of 716 shares by Erick DeVinney of Axogen at 7.68 subject to Rule 16b-3 | 04/01/2024 |
12 | Analysts Expect Breakeven For AxoGen, Inc. Before Long | 04/04/2024 |
13 | Is AxoGen Using Too Much Debt | 04/16/2024 |
| Begin Period Cash Flow | 21.5 M |
Axogen |
Axogen Relative Risk vs. Return Landscape
If you would invest 904.00 in Axogen Inc on January 20, 2024 and sell it today you would lose (249.00) from holding Axogen Inc or give up 27.54% of portfolio value over 90 days. Axogen Inc is currently does not generate positive expected returns and assumes 3.005% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Axogen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Axogen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Axogen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Axogen Inc, and traders can use it to determine the average amount a Axogen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1543
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AXGN |
Estimated Market Risk
| 3.01 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.46 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Axogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Axogen by adding Axogen to a well-diversified portfolio.
Axogen Fundamentals Growth
Axogen Stock prices reflect investors' perceptions of the future prospects and financial health of Axogen, and Axogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Axogen Stock performance.
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.0684 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 343.7 M | ||||
| Shares Outstanding | 43.69 M | ||||
| Price To Earning | (47.07) X | ||||
| Price To Book | 3.29 X | ||||
| Price To Sales | 1.98 X | ||||
| Revenue | 159.01 M | ||||
| Gross Profit | 114.44 M | ||||
| EBITDA | (15.91 M) | ||||
| Net Income | (21.72 M) | ||||
| Cash And Equivalents | 58.03 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 69.29 M | ||||
| Debt To Equity | 0.71 % | ||||
| Current Ratio | 4.52 X | ||||
| Book Value Per Share | 2.22 X | ||||
| Cash Flow From Operations | (5.72 M) | ||||
| Earnings Per Share | (0.51) X | ||||
| Market Capitalization | 305.81 M | ||||
| Total Asset | 196.83 M | ||||
| Retained Earnings | (281.3 M) | ||||
| Working Capital | 57.57 M | ||||
| Current Asset | 35.05 M | ||||
| Current Liabilities | 3.71 M | ||||
About Axogen Performance
To evaluate Axogen Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Axogen generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Axogen Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Axogen Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Axogen's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 269.84 | 156.02 | |
| Return On Tangible Assets | (0.11) | (0.12) | |
| Return On Capital Employed | (0.13) | (0.12) | |
| Return On Assets | (0.11) | (0.12) | |
| Return On Equity | (0.23) | (0.24) |
Things to note about Axogen Inc performance evaluation
Checking the ongoing alerts about Axogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Axogen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Axogen Inc generated a negative expected return over the last 90 days | |
| Axogen Inc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 159.01 M. Net Loss for the year was (21.72 M) with profit before overhead, payroll, taxes, and interest of 114.44 M. | |
| Axogen Inc currently holds about 58.03 M in cash with (5.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37. | |
| Axogen Inc has a frail financial position based on the latest SEC disclosures | |
| Over 77.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from simplywall.st: Is AxoGen Using Too Much Debt |
- Analyzing Axogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Axogen's stock is overvalued or undervalued compared to its peers.
- Examining Axogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Axogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Axogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Axogen's stock. These opinions can provide insight into Axogen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Axogen Inc information on this page should be used as a complementary analysis to other Axogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Axogen Stock analysis
When running Axogen's price analysis, check to measure Axogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axogen is operating at the current time. Most of Axogen's value examination focuses on studying past and present price action to predict the probability of Axogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axogen's price. Additionally, you may evaluate how the addition of Axogen to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Axogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Revenue Per Share 3.708 | Quarterly Revenue Growth 0.187 | Return On Assets (0.07) | Return On Equity (0.22) |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.